CAS:860352-01-8

860352-01-8 Technical Data:

Price and Availability of Cas No:860352-01-8

Cas : 860352-01-8 M.Wt: 362.4218
Cas : 860352-01-8 Formula: C17H19FN4O2S
Cas : 860352-01-8 Purity: >98 %
Cas : 860352-01-8 Storage: at 20℃ 2 years
Cas : 860352-01-8 Solubility: 10 mM in DMSO
Cas : 860352-01-8 Name: AZD-7762

USD
5mg/$70	In-stock
10mg/$110	In-stock
50mg/$330	In-stock
100mg/$468	In-stock
1g	Get quote
5g	Get quote
>10g	Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please inquire via sales@chemexpress.cn or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Online Inquiry

Inquiry Online

Hide

Salutation:		Country:
Customer:		Company Name:
Email:		Requested quantity:
Remarks:

860352-01-8 Data Sheet:

Introduction of 860352-01-8 :
AZD-7762 is a potent ATP-competitive checkpoint kinase (Chk) inhibitor in with IC₅₀ of 5 nM for Chk1. IC50 & Target: IC50: 5 nM (ChK1)^[1] In Vitro: AZD-7762 (AZD7762) is an equally potent inhibitor of Chk1 and Chk2 in vitro. AZD-7762 potently inhibits Chk1 and Chk2, abrogates DNA damage-induced S and G₂ checkpoints, enhances the efficacy of gemcitabine and topotecan, and modulates downstream checkpoint pathway proteins. AZD-7762 potently inhibits Chk1 phosphorylation of a cdc25C peptide with an IC₅₀ of 5 nM as measured by a scintillation proximity assay. The K_i for AZD-7762 is determined to be 3.6 nM. Kinetic characterization suggests that AZD-7762 binds in the ATP-binding site of Chk1 and is thought to compete directly for ATP binding in a reversible manner. AZD-7762 is shown to abrogate the G₂ arrest induced by Camptothecin with an average EC₅₀ of 10 nM (n=12) and maximal abrogation in the range of 100 nM^[1]. In Vivo: In the rat H460-DNp53 xenograft study, AZD-7762 (AZD7762) potentiates the antitumor activity of Gemcitabine in a dose-dependent manner by a decrease in %T/C with increasing dose (48% and 32%, 10 and 20 mg/kg AZD-7762, respectively). In the mouse xenograft study in combination with Irinotecan, SW620 established tumors are treated with vehicle, Irinotecan alone, AZD-7762 alone, or AZD-7762 in combination with Irinotecan. AZD-7762 dosed alone shows insignificant antitumor activity, whereas Irinotecan alone displays striking and significant activity (%T/C with increasing dose is 9 and 1, respectively ). In combination with AZD-7762, %T/C increases significantly to -66% and -67%, respectively^[1]. AZD7762 combination with CX-5461 induces cancer cell death of Tp53-null (Tp53^-/-) Eμ-Myc lymphoma cells in vitro and in vivo^[2].

References on 860352-01-8 :

Insert title here

Products are for research use only. Not for human use. We do not sell to patients. Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China
TEL: 86-21-58998590 FAX: 86-21-53700326, 86-21-58998590 E-mail： sales@chemexpress.cn